STRO
Sutro Biopharma, Inc.stockNASDAQ
At CloseNov 18, 2026 3:59:59 PM EST
8.53USD-4.372%(-0.39)307,218
After-hoursNov 18, 2026 4:27:30 PM EST
8.50USD-0.352%(-0.03)
STRO Financials
In Q3 FY 2026 (ended ), Sutro Biopharma, Inc. (STRO) reported revenue of $9.1M, net income of −$31.49M, operating cash flow of −$22.45M, and assets of $176.65M (filed ).
Loading financial statements…